Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease
MASAÏ
1 other identifier
observational
242
1 country
3
Brief Summary
Salivary gland ultrasonography is identified as a valuable diagnostic tool and potential criteria item for disease classification of sjögren's syndrome and evaluate evolution of parenchyma. The investigators have to include 242 patients. The objective is to evaluate the modification of ultrasonographic abnormalities according to disease in primary Sjögren syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2019
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2019
CompletedFirst Submitted
Initial submission to the registry
December 19, 2019
CompletedFirst Posted
Study publicly available on registry
December 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2020
CompletedDecember 27, 2019
December 1, 2019
6 months
December 19, 2019
December 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence or absence of parenchymal abdnormalities.
Presence or absence of parenchymal abdnormalities. Scored following a standardized fill and according to disease duration
inclusion
Secondary Outcomes (1)
Parenchymal abnormalities according to disease activity
inclusion
Eligibility Criteria
Patients with Primary sjögren syndrome
You may qualify if:
- Male or female patient ≥ 18 years
- Primary sjögren syndrome according of age to 2002 or 2016 classification criteria
You may not qualify if:
- Secondary sjögren syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
CHRU de Brest
Brest, 29609, France
CHU de LILLE
Lille, 59037, France
CHU de MONTEPELLIER
Montpellier, 34295, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2019
First Posted
December 27, 2019
Study Start
November 20, 2019
Primary Completion
May 20, 2020
Study Completion
May 20, 2020
Last Updated
December 27, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning one year and ending two years following the publication
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.
All collected data that underlie results in a publication